E-LIB Suche - Ergebnisse für: Phillips, Christine

1

Risk Factors for Hematotoxicity Following Tisagenlecleucel ..:

McNerney, Kevin Owen ; Fabrizio, Vanessa A. ; Talleur, Aimee C....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S219-S220 , 2024

Link: https://doi.org/10.1016/..

2

Diagnostic delay of sarcoidosis: an integrated systematic r..:

Namsrai, Tergel ; Phillips, Christine ; Parkinson, Anne...
Orphanet Journal of Rare Diseases. 19 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Real World Outcomes for AYA Patients with Relapsed/Refracto..:

Lust, Hannah ; Roloff, Gregory ; Schultz, Liora Michal...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S39-S40 , 2024

Link: https://doi.org/10.1016/..

4

Establishing Costs for Commercial Chimeric Antigen Receptor..:

Satwani, Prakash ; Chao, Karen ; Lopez-Garcia, Maria...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S224-S225 , 2024

Link: https://doi.org/10.1016/..

5

High Disease Burden and Severe Neutropenia Predict HLH Toxi..:

McNerney, Kevin O. ; Lim, Stephanie Si ; Miller, Alexandra...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S202-S203 , 2023

Link: https://doi.org/10.1016/..

6

Diagnostic delay of sarcoidosis: Protocol for an integrated..:

Namsrai, Tergel ; Phillips, Christine ; Desborough, Jane...
PLOS ONE. 18 (2023) 2 - p. e0269762 , 2023

Link: https://doi.org/10.1371/..

7

Tisagenlecleucel utilisation and outcomes across refractory..:

Barsan, Valentin ; Li, Yimei ; Prabhu, Snehit...
eClinicalMedicine. 65 (2023) - p. 102268 , 2023

Link: https://doi.org/10.1016/..

8

'A human face and voice': transgender patient-educator and ..:

Ruprecht, Ky ; Dunlop, William ; Wah, Estee..
BMC Medical Education. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

9

DEVELOPMENT AND ACCEPTABILITY OF A MOBILE APP FOR MONITORIN..:

Mcvey, Ava ; Cooper, Kalvry ; Stephan, Abigail...
Innovation in Aging. 7 (2023) Supplement_1 - p. 678-678 , 2023

Link: https://doi.org/10.1093/..

10

Durable remissions achieved with reinfusion of CD19‐directe..:

Galletta, Thomas J. ; Rubinstein, Jeremy D. ; Krupski, Christa...
Pediatric Blood & Cancer. 70 (2023) 5 - p. , 2023

Link: https://doi.org/10.1002/..

11

Driven by need, shaped by access: Heterogeneity in patient ..:

Miele, Andrew S. ; Fleury, Marie-Josée ; Zeluff, Heather...
Drug and Alcohol Dependence. 246 (2023) - p. 109825 , 2023

Link: https://doi.org/10.1016/..

12

Reduced-Intensity Conditioning Mitigates Risk for Primary O..:

Bender, Jonathan D. ; Oquendo-del Toro, Helen ; Benoit, Janie...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. 130.e1-130.e8 , 2023

Link: https://doi.org/10.1016/..

13

Toward Diabetes Device Development That Is Mindful to the N..:

Brew-Sam, Nicola ; Parkinson, Anne ; Chhabra, Madhur...
JMIR Diabetes. 8 (2023) - p. e43377 , 2023

Link: https://doi.org/10.2196/..

14

Higher doses of tisagenlecleucel are associated with improv..:

Stefanski, Heather E. ; Eaton, Anne ; Baggott, Christina...
Blood Advances. 7 (2023) 4 - p. 541-548 , 2023

Link: https://doi.org/10.1182/..

15

Mediport Use As an Acceptable Standard for CAR T Cell Infus..:

Eylon, Maya ; Baggott, Christina ; Prabhu, Snehit...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S195-S196 , 2023

Link: https://doi.org/10.1016/..